🔎 Trials Near Me

Beranda › Tumor Otak › Utah

Uji klinis Tumor Otak di Utah

8 studi untuk Tumor Otak mencari peserta di lokasi di Utah.

Kota di Utah

Teks studi resmi (Bahasa Inggris)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04511013

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • Primary Children's Hospital, Salt Lake City
Menerima pesertaFase 2
59 Months · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05535166

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • START Mountain Region, West Valley City
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

  • Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT02390518

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • University of Utah, Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06810544

Guided Meditation During Radiation Therapy for Brain Tumors

  • Huntsman Cancer Institute, Salt Lake City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT06165653

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

  • Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2025 · NCT06194929

Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.